Breast Cancer Drug Among Six New Treatments Approved for NHS Scotland
The Scottish Medicines Consortium (SMC) has approved six new drugs for use within NHS Scotland, including a breakthrough breast cancer treatment that could extend the lives of patients battling advanced forms of the disease. However, a promising Alzheimer’s medication was denied due to concerns over cost-effectiveness. New Hope for Breast Cancer Patients Among the newly approved treatments is Olaparib, a targeted therapy for adults with breast cancer linked to the BRCA1 gene or those with mutated HER2-negative advanced breast cancer. Marketed under the brand name Lynparza, the drug offers fresh hope for patients with limited treatment options. Claire Rowney, Chief…
